Literature DB >> 15837624

The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia.

Deepa B Shankar1, Jerry C Cheng, Kentaro Kinjo, Noah Federman, Theodore B Moore, Amandip Gill, Nagesh P Rao, Elliot M Landaw, Kathleen M Sakamoto.   

Abstract

CREB is a transcription factor that functions in glucose homeostasis, growth factor-dependent cell survival, and memory. In this study, we describe a role of CREB in human cancer. CREB overexpression is associated with increased risk of relapse and decreased event-free survival. CREB levels are elevated in blast cells from patients with acute myeloid leukemia. To understand the role of CREB in leukemogenesis, we studied the biological consequences of CREB overexpression in primary human leukemia cells, leukemia cell lines, and transgenic mice. Our results demonstrate that CREB promotes abnormal proliferation and survival of myeloid cells in vitro and in vivo through upregulation of specific target genes. Thus, we report that CREB is implicated in myeloid cell transformation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15837624     DOI: 10.1016/j.ccr.2005.02.018

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  102 in total

1.  Targeting CREB for cancer therapy: friend or foe.

Authors:  Xiangshu Xiao; Bingbing X Li; Bryan Mitton; Alan Ikeda; Kathleen M Sakamoto
Journal:  Curr Cancer Drug Targets       Date:  2010-06       Impact factor: 3.428

2.  TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation.

Authors:  Ali I Kuraishy; Samuel W French; Mara Sherman; Marco Herling; Dan Jones; Randolph Wall; Michael A Teitell
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

3.  Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma.

Authors:  James R Cerhan; Stephen M Ansell; Zachary S Fredericksen; Neil E Kay; Mark Liebow; Timothy G Call; Ahmet Dogan; Julie M Cunningham; Alice H Wang; Wen Liu-Mares; William R Macon; Diane Jelinek; Thomas E Witzig; Thomas M Habermann; Susan L Slager
Journal:  Blood       Date:  2007-09-07       Impact factor: 22.113

4.  Protein signature for non-small cell lung cancer prognosis.

Authors:  Wei Liu; Yong Wu; Libo Wang; Ling Gao; Yingping Wang; Xiaoliang Liu; Kai Zhang; Jena Song; Hongxia Wang; Thomas A Bayer; Laurel Glaser; Yezhou Sun; Weijia Zhang; Michael Cutaia; David Y Zhang; Fei Ye
Journal:  Am J Cancer Res       Date:  2014-05-26       Impact factor: 6.166

Review 5.  Understanding the CREB1-miRNA feedback loop in human malignancies.

Authors:  Ya-Wen Wang; Xu Chen; Rong Ma; Peng Gao
Journal:  Tumour Biol       Date:  2016-04-09

6.  Akt/cAMP-responsive element binding protein/cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by Nexrutine, a Phellodendron amurense bark extract.

Authors:  Addanki P Kumar; Shylesh Bhaskaran; Manonmani Ganapathy; Katherine Crosby; Michael D Davis; Peter Kochunov; John Schoolfield; I-Tien Yeh; Dean A Troyer; Rita Ghosh
Journal:  Clin Cancer Res       Date:  2007-05-01       Impact factor: 12.531

7.  Growth suppression of lung cancer cells by targeting cyclic AMP response element-binding protein.

Authors:  Sita Aggarwal; Seung-Wook Kim; Seung-Hee Ryu; Wen-Cheng Chung; Ja Seok Koo
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701

8.  Cyclic AMP response element-binding protein overexpression: a feature associated with negative prognosis in never smokers with non-small cell lung cancer.

Authors:  Hye-Sook Seo; Diane D Liu; B Nebiyou Bekele; Mi-Kyoung Kim; Katherine Pisters; Scott M Lippman; Ignacio I Wistuba; Ja Seok Koo
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

9.  Expression profile of CREB knockdown in myeloid leukemia cells.

Authors:  Matteo Pellegrini; Jerry C Cheng; Jon Voutila; Dejah Judelson; Julie Taylor; Stanley F Nelson; Kathleen M Sakamoto
Journal:  BMC Cancer       Date:  2008-09-18       Impact factor: 4.430

10.  Clinical activities of the epidermal growth factor receptor family inhibitors in breast cancer.

Authors:  Elizabeth S Henson; James B Johnston; Marek Los; Spencer B Gibson
Journal:  Biologics       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.